Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotype-adapted Tacrolimus dosing in renal transplantation
NCT00552201Phase 4Completed
- Sponsor
- CHU Amiens-Picardie
- Start
- Apr 2006
- Primary completion
- Jan 2008
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in kidney transplantation, sponsored by CHU Amiens-Picardie. Started Apr 2006; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00552201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00552201.